Investor Update

MezLight has developed a solid partnership with our contract manufacturer Bridgemedica. Our teams have built trust and confidence in each other and it’s a delight to be a part of. While parts sourcing and tooling revisions have delayed our launch timeline to 1Q 2021 we are holding weekly meetings to make sure we are a priority to all of our suppliers. Our team continues to collaborate daily with Bridgemedica to efficiently address any issues. After the final sourcing decisions were made, we are proud to say that all components are still fabricated by US suppliers, ensuring that MezLight will be 100% assembled and made in the USA, as promised.

Over the next few months we will be finalizing all injection molded parts, optimizing the assembly and test procedures on the production line, and building our DV&V (Design Verification and Validation) product. This set of 25 units will be used to conduct the testing necessary to satisfy our Quality System requirements and allow us to register with the FDA prior to production distribution. Our regulatory consultant Skip Farhina, of Strategic Device Solutions, has written our test protocols to include information needed to enable us to apply for European CE mark later in 2021. The details for labeling and packaging are also being finalized.

It has been a terrific experience working closely with Bridgemedica. Bridgemedica has been highly responsive to our request  to consider hiring female and/or underrepresented minority engineers. They did not hesitate to make this a priority and the stand-out star on our project has been mechanical engineer Sabrina DiMartino, a

Mexican-American graduate of the Wentworth Institute of Technology. Within the last 60 days they have hired and trained a new supervisor of production and she will have responsibility for the MezLight production line.